🇺🇸 FDA
Pipeline program

TEZ

VX15-440-101

Phase 3 small_molecule completed

Quick answer

TEZ for Cystic Fibrosis is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 2 ClinicalTrials.gov record(s).

Program details

Company
Vertex Pharmaceuticals (Ireland) Limited
Indication
Cystic Fibrosis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials